Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece
Clinical trial NCT02626013 · COMPLETED
Trial details
- NCT number
- NCT02626013
- Sponsor
- Genesis Pharma S.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-04-12
- Primary completion
- 2018-09-12
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.